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and 0.006 in women. CONCLUSION: There was an association
between height and health-related utility. The determinants of
this association are not as yet clear and are likely to be complex
involving social, environmental and other factors. Treatments
are available to increase the height of children with short stature.
This analysis suggests that these treatments would be cost effec-
tive depending upon effect and price.
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OBJECTIVE: To determine whether the administration of
epoetin alfa (rHuEPO) reduced the amount of blood transfusions
required by patients during surgical intensive care unit (SICU)
admission. METHODS: A retrospective cohort of all adult
patients admitted to the SICU of the LAC + USC Medical Center
between January, 2001 and December, 2003, who remained in
the SICU for at least ﬁve days. Patients who met entry criteria
were stratiﬁed into two groups based on whether rHuEPO was
administered. Series of T-tests were performed using variables
such as, demographics, laboratory data, monitoring parameters,
medication dosing, intervention histories, and mortality between
the groups to determine whether or not any differences existed
after stratiﬁcation. Multivariate stepwise logistic regression
analyses were conducted to determine the signiﬁcant covariates
which were associated with rHuEPO administration. Selection
bias was adjusted by matching subjects using propensity score
methods. RESULTS: The primary efﬁcacy end point was the
amount of packed red blood cells (PRBC) transfused per patient
after day-seven of SICU stay between rHuEPO and non-rHuEPO
groups. After matching for likelihood of receiving rHuEPO using
propensity scores method, rHuEPO patients received 900.1 
± 1678.2mL of PRBC after day-seven of SICU stay while non-
rHuEPO patients received 875.1 ± 1687.2mL of PRBC (p =
0.9165). There was no statistical difference in transfusion inde-
pendence between the number of patients in the matched groups
who received transfusions after day-seven of SICU stay (rHuEPO
47/100 (47%) vs. non-rHuEPO 51/100 (51%), p = 0.5715) or
for the last recorded hematocrit (Hct) values of SICU stay
(rHuEPO 30.3 ± 5.6mg/dL, non-rHuEPO 30.0 ± 3.5mg/dL, 
p = 0.5540). There also was no statistical difference between
matched groups for SICU mortality (rHuEPO 11/100 (11%),
non-rHuEPO 15/100 (15%), p = 0.4003). CONCLUSIONS: In
our cohort, administration of rHuEPO was not associated with
a difference in units of PRBC transfused, transfusion indepen-
dence, discharge Hct or SICU mortality.
PHM2
IMPACT OF ANEMIA ON IN-HOSPITAL FALLS: A MATCHED
CASE-CONTROL STUDY
Mallik AV1, Coley KC1, Kirisci L1, Painter L2
1University of Pittsburgh, Pittsburgh, PA, USA; 2University of Pittsburgh
Medical Center, Pittsburgh, PA, USA
OBJECTIVES: The objective of this study was to determine
whether anemia contributes to the likelihood of experiencing an
in-hospital fall. METHODS: A retrospective case-control study
was conducted at the University of Pittsburgh Medical Center
between January 1, 1998 and June 30, 2003. To be included as
a case, patients had to be ≥18 years of age, hospitalized for >24
hours, have a hemoglobin (Hgb) test during their stay, and expe-
rience an in-hospital fall. Control patients were matched 1 :1 on
age, gender, race, service, length of stay (±one day), and year of
admission. Anemia was assessed using the ﬁrst Hgb value and
deﬁned as Hgb < 12g/dL for females or Hgb < 13g/dL for males.
A reference fall date was calculated for each control patient by
using the same timeframe (e.g. days to fall) as its matched fall
case. Drug utilization was identiﬁed two-days before the fall date
for cases and the reference fall date for controls. Statistics per-
formed were T-tests, chi-square, and logistic regression using
“fall” as the dependent variable and comorbidities, drug class,
and anemia status as covariates. RESULTS: There were a total
of 1248 patients identiﬁed for study. The mean age was 68 ± 15
years, 49% were female, and 89% were Caucasian. Cases were
more likely to have congestive heart failure (23% vs. 19%),
chronic kidney disease–CKD (12% vs. 7%), and diabetes (29%
vs. 23%) and be receiving antidepressants (27% vs. 21%), ben-
zodiazepines (30% vs. 24%), and anticonvulsants (22% vs.
15%). Regression analysis demonstrated that patients with CKD
(OR = 1.8, p = 0.003), pneumonia (OR = 1.6, p = 0.03), and
those receiving antidepressants (OR = 1.3, p = 0.02), benzodi-
azepines (OR = 1.4, p = 0.007), and anticonvulsants (OR = 1.5,
p = 0.006) were more likely to experience an in-hospital fall.
CONCLUSION: In this case-control study, anemia did not con-
tribute to in-hospital falls.
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OBJECTIVES: The objectives of this study were to describe the
characteristics of patients experiencing in-hospital falls, to iden-
tify the prevalence of anemia, and to evaluate whether anemia
contributes to longer length of stay. METHODS: A retrospective
study of patients experiencing an in-hospital fall between
January 1, 1998 and June 30, 2003 was conducted at the Uni-
versity of Pittsburgh Medical Center. To be included, patients
had to be ≥18 years of age, admitted into the hospital for >24
hours, and have a hemoglobin (Hgb) test during their stay.
Demographics, comorbidities, Hgb tests, and drug groups were
extracted from a medical record data repository. Anemia was
assessed using the last Hgb value prior to the fall date and
deﬁned as Hgb < 12g/dL for females or Hgb < 13g/dL for males.
Statistics included T-tests, chi-square, and a linear regression
analysis using length of stay (log transformed) after the fall 
date as the dependent variable and demographics, comorbidities,
drug class, and anemia status as independent variables.
RESULTS: There were 1518 patients that met study criteria. 
The mean age was 65 ± 16 years, 49% were female, 81% were
Caucasian, and 79% were anemic. Most patients (60%) fell
within one week of hospital admission. Anemic patients were
more likely to have chronic kidney disease (8% vs. 4%) and gas-
trointestinal diseases (20% vs. 8%). Drug utilization was similar
except that anemic patients were less likely to receive anticon-
vulsants (20% vs. 26%). A linear regression analysis showed 
that patients who were younger (p = 0.01), had cardiac arrhyth-
mias (p < 0.001), pneumonia (p < 0.001), and gastrointestinal
disease (p < 0.001) and those receiving antihistamines (p = 0.02)
were more likely to have longer lengths of stay. CONCLUSION:
The majority of patients experiencing an in-hospital fall were
anemic, however, anemia did not contribute to increased length
of stay.
